检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Results from the First Phase 3 Crovalimab (C5 Inhibitor) Study (COMMODORE 3): Efficacy and Safety in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Hui Liu,Linghui Xia,Jianyu Weng,Fengkui Zhang,Chuan He,Sujun Gao,Jinsong Jia,Alice C. Chang,Pontus Lundberg,Camelia S. Sima,Jane Shi,Zhenyu Xiao,Yuchen Zhang,Zilu Zhang,Rong Fu

Blood（2022）

引用 2|浏览11
暂无评分
关键词
paroxysmal nocturnal hemoglobinuria,c5 inhibitor,crovalimab,inhibitor-naive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要